Publication:
Predictors of positive response to beta-blockers for treatment of premature ventricular complexes

dc.contributor.authorsDemir, Serdar; Gulsen, Kamil; Kepez, Alper; Uslu, Abdulkadir; Kup, Ayhan; Celik, Mehmet; Kanar, Batur Gonenc; Yildirim, Cagan; Tulumen, Erol; Akgun, Taylan
dc.date.accessioned2022-04-25T00:12:14Z
dc.date.accessioned2026-01-11T15:17:17Z
dc.date.available2022-04-25T00:12:14Z
dc.date.issued2022
dc.description.abstractBackground: The aim of the present study is to investigate the possible factors that might be predictive of effective antiarrhythmic effect of beta-blockers on premature ventricular complexes (PVC). Methods: Data of 190 eligible consecutive patients to whom beta-blocker therapy had been initiated for treatment of PVC's were retrospectively evaluated. The Holter recording acquired before beta-blocker initiation and the first Holter acquired after beta blocker initiation during follow up was comprehensively evaluated for each patient. Parameters obtained from pre- and post-beta-blocker 24 h Holter recordings were compared with each other and possible predictors were evaluated for positive response to beta-blocker therapy. Results: Sixty-one patients (32.1%) were observed to respond beta-blocker therapy with at least 50% reduction of daily PVC burden. Patients who responded to beta-blockers had significantly higher ratio of patients who had positive correlation between hourly heart rate and corresponding hourly PVC number (fast HR-PVC status) compared with non-responders (73.8% vs 48.1%, p < 0.001). Binary logistic regression analysis revealed PVC QRS width (Odds ratio: 0.971; p: 0.037) and fast HR-PVC status (Odds ratio: 2.935; p: 0.007) as the independent predictors of positive response to beta-blockers for treatment of PVC. Conclusion: Positive correlation between hourly heart rate and PVC incidence was found to be independent positive predictor and PVC QRS width was found to be independent negative predictor of beta-blocker success in our study. This observation might have important clinical implications to guide medical treatment of PVCs in clinical practice.
dc.identifier.doi10.1016/j.jelectrocard.2021.11.036
dc.identifier.eissn1532-8430
dc.identifier.issn0022-0736
dc.identifier.pubmed34922221
dc.identifier.urihttps://hdl.handle.net/11424/264045
dc.identifier.wosWOS:000746079700013
dc.languageeng
dc.publisherCHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
dc.relation.ispartofJOURNAL OF ELECTROCARDIOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPremature ventricular complex
dc.subjectBeta-blocker
dc.subjectHolter recording
dc.subjectDiurnal variability of premature ventricular
dc.subjectcomplexes
dc.subjectCOUPLING INTERVAL VARIABILITY
dc.subjectHEART-RATE
dc.subjectCONTRACTIONS
dc.subjectSUPPRESSION
dc.subjectSLEEP
dc.titlePredictors of positive response to beta-blockers for treatment of premature ventricular complexes
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage55
oaire.citation.startPage50
oaire.citation.titleJOURNAL OF ELECTROCARDIOLOGY
oaire.citation.volume70

Files